These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 24411077)

  • 1. AD-linked, toxic NH2 human tau affects the quality control of mitochondria in neurons.
    Amadoro G; Corsetti V; Florenzano F; Atlante A; Ciotti MT; Mongiardi MP; Bussani R; Nicolin V; Nori SL; Campanella M; Calissano P
    Neurobiol Dis; 2014 Feb; 62():489-507. PubMed ID: 24411077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction between NH(2)-tau fragment and Aβ in Alzheimer's disease mitochondria contributes to the synaptic deterioration.
    Amadoro G; Corsetti V; Atlante A; Florenzano F; Capsoni S; Bussani R; Mercanti D; Calissano P
    Neurobiol Aging; 2012 Apr; 33(4):833.e1-25. PubMed ID: 21958963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NH2-truncated human tau induces deregulated mitophagy in neurons by aberrant recruitment of Parkin and UCHL-1: implications in Alzheimer's disease.
    Corsetti V; Florenzano F; Atlante A; Bobba A; Ciotti MT; Natale F; Della Valle F; Borreca A; Manca A; Meli G; Ferraina C; Feligioni M; D'Aguanno S; Bussani R; Ammassari-Teule M; Nicolin V; Calissano P; Amadoro G
    Hum Mol Genet; 2015 Jun; 24(11):3058-81. PubMed ID: 25687137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A NH2 tau fragment targets neuronal mitochondria at AD synapses: possible implications for neurodegeneration.
    Amadoro G; Corsetti V; Stringaro A; Colone M; D'Aguanno S; Meli G; Ciotti M; Sancesario G; Cattaneo A; Bussani R; Mercanti D; Calissano P
    J Alzheimers Dis; 2010; 21(2):445-70. PubMed ID: 20571215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dissecting the molecular mechanism by which NH2htau and Aβ1-42 peptides impair mitochondrial ANT-1 in Alzheimer disease.
    Bobba A; Amadoro G; Petragallo VA; Calissano P; Atlante A
    Biochim Biophys Acta; 2013 Jul; 1827(7):848-60. PubMed ID: 23583906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amyloid Beta and Phosphorylated Tau-Induced Defective Autophagy and Mitophagy in Alzheimer's Disease.
    Reddy PH; Oliver DM
    Cells; 2019 May; 8(5):. PubMed ID: 31121890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Caspase-Cleaved Tau Impairs Mitochondrial Dynamics in Alzheimer's Disease.
    Pérez MJ; Vergara-Pulgar K; Jara C; Cabezas-Opazo F; Quintanilla RA
    Mol Neurobiol; 2018 Feb; 55(2):1004-1018. PubMed ID: 28084594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diminished parkin solubility and co-localization with intraneuronal amyloid-β are associated with autophagic defects in Alzheimer's disease.
    Lonskaya I; Shekoyan AR; Hebron ML; Desforges N; Algarzae NK; Moussa CE
    J Alzheimers Dis; 2013; 33(1):231-47. PubMed ID: 22954671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amyloid beta impairs mitochondrial anterograde transport and degenerates synapses in Alzheimer's disease neurons.
    Calkins MJ; Reddy PH
    Biochim Biophys Acta; 2011 Apr; 1812(4):507-13. PubMed ID: 21241801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AD-Related N-Terminal Truncated Tau Is Sufficient to Recapitulate In Vivo the Early Perturbations of Human Neuropathology: Implications for Immunotherapy.
    Borreca A; Latina V; Corsetti V; Middei S; Piccinin S; Della Valle F; Bussani R; Ammassari-Teule M; Nisticò R; Calissano P; Amadoro G
    Mol Neurobiol; 2018 Oct; 55(10):8124-8153. PubMed ID: 29508283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tau accumulation impairs mitophagy via increasing mitochondrial membrane potential and reducing mitochondrial Parkin.
    Hu Y; Li XC; Wang ZH; Luo Y; Zhang X; Liu XP; Feng Q; Wang Q; Yue Z; Chen Z; Ye K; Wang JZ; Liu GP
    Oncotarget; 2016 Apr; 7(14):17356-68. PubMed ID: 26943044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebrospinal fluid levels of a 20-22 kDa NH2 fragment of human tau provide a novel neuronal injury biomarker in Alzheimer's disease and other dementias.
    Amadoro G; Corsetti V; Sancesario GM; Lubrano A; Melchiorri G; Bernardini S; Calissano P; Sancesario G
    J Alzheimers Dis; 2014; 42(1):211-26. PubMed ID: 24851856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Protective Effect of Icariin on Mitochondrial Transport and Distribution in Primary Hippocampal Neurons from 3× Tg-AD Mice.
    Chen Y; Han S; Huang X; Ni J; He X
    Int J Mol Sci; 2016 Jan; 17(2):. PubMed ID: 26828481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RNA silencing of genes involved in Alzheimer's disease enhances mitochondrial function and synaptic activity.
    Manczak M; Reddy PH
    Biochim Biophys Acta; 2013 Dec; 1832(12):2368-78. PubMed ID: 24063855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A peptide containing residues 26-44 of tau protein impairs mitochondrial oxidative phosphorylation acting at the level of the adenine nucleotide translocator.
    Atlante A; Amadoro G; Bobba A; de Bari L; Corsetti V; Pappalardo G; Marra E; Calissano P; Passarella S
    Biochim Biophys Acta; 2008 Oct; 1777(10):1289-300. PubMed ID: 18725189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitochondrial Dysfunction Contributes to the Pathogenesis of Alzheimer's Disease.
    Cabezas-Opazo FA; Vergara-Pulgar K; Pérez MJ; Jara C; Osorio-Fuentealba C; Quintanilla RA
    Oxid Med Cell Longev; 2015; 2015():509654. PubMed ID: 26221414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced dynamin-related protein 1 protects against phosphorylated Tau-induced mitochondrial dysfunction and synaptic damage in Alzheimer's disease.
    Kandimalla R; Manczak M; Fry D; Suneetha Y; Sesaki H; Reddy PH
    Hum Mol Genet; 2016 Nov; 25(22):4881-4897. PubMed ID: 28173111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of the superoxide dismutase/catalase mimetic EUK-207 in a mouse model of Alzheimer's disease: protection against and interruption of progression of amyloid and tau pathology and cognitive decline.
    Clausen A; Xu X; Bi X; Baudry M
    J Alzheimers Dis; 2012; 30(1):183-208. PubMed ID: 22406441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hippocampal tau oligomerization early in tau pathology coincides with a transient alteration of mitochondrial homeostasis and DNA repair in a mouse model of tauopathy.
    Zheng J; Akbari M; Schirmer C; Reynaert ML; Loyens A; Lefebvre B; Buée L; Croteau DL; Galas MC; Bohr VA
    Acta Neuropathol Commun; 2020 Mar; 8(1):25. PubMed ID: 32131898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitochondrial Aspects of Synaptic Dysfunction in Alzheimer's Disease.
    Cai Q; Tammineni P
    J Alzheimers Dis; 2017; 57(4):1087-1103. PubMed ID: 27767992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.